Carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase-deficiency)
- PMID: 10571009
- DOI: 10.1016/s0925-4439(99)00073-3
Carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase-deficiency)
Abstract
The carbohydrate-deficient glycoprotein or CDG syndromes (OMIM 212065) are a recently delineated group of genetic, multisystem diseases with variable dysmorphic features. The known CDG syndromes are characterized by a partial deficiency of the N-linked glycans of secretory glycoproteins, lysosomal enzymes, and probably also membranous glycoproteins. Due to the deficiency of terminal N-acetylneuraminic acid or sialic acid, the glycan changes can be observed in serum transferrin or other glycoproteins using isoelectrofocusing with immunofixation as the most widely used diagnostic technique. Most patients show a serum sialotransferrin pattern characterized by increased di- and asialotransferrin bands (type I pattern). The majority of patients with type I are phosphomannomutase deficient (type IA), while in a few other patients, deficiencies of phosphomannose isomerase (type IB) or endoplasmic reticulum glucosyltransferase (type IC) have been demonstrated. This review is an update on CDG syndrome type IA.
Similar articles
-
Molecular basis of carbohydrate-deficient glycoprotein syndromes type I with normal phosphomannomutase activity.Biochim Biophys Acta. 1999 Oct 8;1455(2-3):167-78. doi: 10.1016/s0925-4439(99)00072-1. Biochim Biophys Acta. 1999. PMID: 10571010 Review.
-
Komrower Lecture. Congenital disorders of glycosylation (CDG): it's all in it!J Inherit Metab Dis. 2003;26(2-3):99-118. doi: 10.1023/a:1024431131208. J Inherit Metab Dis. 2003. PMID: 12889654
-
Continuous mannose infusion in carbohydrate-deficient glycoprotein syndrome type I.Acta Paediatr. 1997 Oct;86(10):1138-40. doi: 10.1111/j.1651-2227.1997.tb14825.x. Acta Paediatr. 1997. PMID: 9350901
-
A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency.Biochem Biophys Res Commun. 1998 Apr 7;245(1):38-42. doi: 10.1006/bbrc.1998.8385. Biochem Biophys Res Commun. 1998. PMID: 9535779
-
[Congenital disorder of glycosylation type Ia (CDG Ia) - underdiagnosed entity?].Duodecim. 2016;132(3):253-9. Duodecim. 2016. PMID: 26951030 Review. Finnish.
Cited by
-
N-linked glycosylation of Kv1.2 voltage-gated potassium channel facilitates cell surface expression and enhances the stability of internalized channels.J Physiol. 2016 Nov 15;594(22):6701-6713. doi: 10.1113/JP272394. Epub 2016 Aug 2. J Physiol. 2016. PMID: 27377235 Free PMC article.
-
Investigating diversity in human plasma proteins.Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):10852-7. doi: 10.1073/pnas.0500426102. Epub 2005 Jul 25. Proc Natl Acad Sci U S A. 2005. PMID: 16043703 Free PMC article.
-
Variation of the serum N-glycosylation during the pregnancy of a MPI-CDG patient.JIMD Rep. 2021 Sep 17;62(1):22-29. doi: 10.1002/jmd2.12247. eCollection 2021 Nov. JIMD Rep. 2021. PMID: 34765394 Free PMC article.
-
Glycosylation affects rat Kv1.1 potassium channel gating by a combined surface potential and cooperative subunit interaction mechanism.J Physiol. 2003 Jul 1;550(Pt 1):51-66. doi: 10.1113/jphysiol.2003.040337. J Physiol. 2003. PMID: 12879861 Free PMC article.
-
The joys of HexNAc. The synthesis and function of N- and O-glycan branches.Glycoconj J. 2000 Jul-Sep;17(7-9):465-83. doi: 10.1023/a:1011010206774. Glycoconj J. 2000. PMID: 11421343 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
